… and our rating system makes high-quality companies more likely to reach 5 stars on a price dip. As my colleague Amy Arnott pointed out recently , the market may be a little frothy right now, and a manageable 65 stocks presently seem undervalued …
… and our rating system makes high-quality companies more likely to reach 5 stars on a price dip. As my colleague Amy Arnott pointed out two weeks ago , the market may be a little frothy right now, and a manageable 65 stocks presently seem undervalued …
… support for customers. More Reading "Stocks to Watch" , by Haywood Kelly "Five Stocks to Buy and One to Avoid" , by Mark Sellers "More Stock Ideas from Great Managers" , by Amy Arnott "Screens for Great Stocks" , by Haywood Kelly
… Even with holiday sales looking surprisingly robust, Amazon is still too expensive." Schering-Plough SGP, by Amy Arnott "Even assuming that its hepatitis C franchise helps drive high-single-digit sales growth in 2002, the stock still …
… Nichols "We continue to believe AOL is among the few media stocks worth buying now." Bristol-Myers Squibb BMY, by Amy Arnott "Most of the downside risk has already been wrung out of the stock." JDS Uniphase JDSU, by Jay Ritter "JDS looks …
… prices have been. As the markets fell this week, several stocks began to look cheap. American Home Products AHP, by Amy Arnott "Even with conservative assumptions for revenue growth and margin improvements over the next five years, we calculate …
… the strongest assets in the business--we do believe the stock has gotten a bit ahead of itself." Palm PALM, by Amy Arnott "Our analysis pegs the stock's fair value at about $4 per share, even assuming a decent level of sales growth and …
… trailing EBITDA, there is no room for error should the synergies take longer to realize than expected." Palm PALM, by Amy Arnott "Our analysis pegs the stock's fair value at about $4 per share, even assuming a decent level of sales growth and …
… pressures, two leading fund managers see potential in pharmaceuticals, biotech, and other health-care stocks. by Amy Arnott Stock-Picking Ideas from Legg Mason's Bill Miller The legendary manager says stay focused on long-term potential …
… fall throughout the 1990s should serve as a reality check for investors in both sectors. As Morningstar stock analyst Amy Arnott pointed out in a recent column , "the landscape is littered with biotech startups that were burning through cash five …